Tag: atrial fibrillation

1. Patients with recurrent atrial fibrillation who received cryoballoon ablation were significantly more likely to remain free of subsequent arrhythmia after 1 year compared to those who received antiarrhythmics. 2. Serious procedure-related events were infrequent, and the total number of serious adverse events was similar between groups. Evidence Rating Level: 1...
1. Patients who received rivaroxaban had a statistically significantly longer mean time until occurrence of a major clinical event compared to those who received warfarin. 2. The incidence of secondary-outcome events such as transient ischemic attack (TIA), valve thrombosis, and non-CNS embolism were similar between groups. Evidence Rating Level: 1 (Excellent) Study...
1. Gastrointestinal, genitourinary, or bronchopulmonary bleeding in anticoagulated patients with atrial fibrillation have been associated with higher rates of respective cancer diagnoses. Evidence Rating Level: 2 (Good) Recent registry data suggests that diagnoses of atrial fibrillation (AF) have been associated with higher incidence rates of cancer. Bleeding episodes in anticoagulated patients...
1. Gastrointestinal, genitourinary, or bronchopulmonary bleeding in anticoagulated patients with atrial fibrillation have been associated with higher rates of respective cancer diagnoses. Evidence Rating Level: 2 (Good) Recent registry data suggests that diagnoses of atrial fibrillation (AF) have been associated with higher incidence rates of cancer. Bleeding episodes in anticoagulated patients...
1. A total of 7 medium- and long-chain acylcarnitines were associated with higher risk of atrial fibrillation (AF). 2. Caffeine and acisoga were associated with increased risk of incident AF while beta carotene was associated with a lower risk. Evidence Rating Level: 2 (Good) Atrial fibrillation (AF) is the most common cardiac...
Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source 1. Microbleeds increase risk of intracerebral hemorrhage, ischemic stroke, recurrent stroke, and mortality. 2. Microbleeds do not appear to influence the effects of rivaroxaban treatment. Evidence Rating Level: 2 (Good) Cerebral microbleeds are known to be associated with intracerebral...
1. Low dose edoxaban was superior to placebo in preventing stroke or systemic embolism for very elderly patients with nonvalvular atrial fibrillation at risk of bleeding. 2. Edoxaban did not significantly increase the incidence of major bleeding compared to placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: Atrial fibrillation and age are...
1. Low dose edoxaban was superior to placebo in preventing stroke or systemic embolism for very elderly patients with nonvalvular atrial fibrillation at risk of bleeding. 2. Edoxaban did not significantly increase the incidence of major bleeding compared to placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: Atrial fibrillation and age are...
1. An opportunistic screening protocol for atrial fibrillation was not found to improve diagnostic rates, compared to usual care. Evidence Rating Level: 1 (Excellent) Atrial fibrillation (AF) is a cardiac arrhythmia that increases in prevalence with age. AF can also lead to cardiovascular conditions such as stroke and heart failure. Although...
1. An opportunistic screening protocol for atrial fibrillation was not found to improve diagnostic rates, compared to usual care. Evidence Rating Level: 1 (Excellent) Atrial fibrillation (AF) is a cardiac arrhythmia that increases in prevalence with age. AF can also lead to cardiovascular conditions such as stroke and heart failure. Although...